Poststroke depression biomarkers: a narrative review OA Levada, AS Troyan Frontiers in Neurology 9, 362121, 2018 | 74 | 2018 |
Insulin-like growth factor-1: a possible marker for emotional and cognitive disturbances, and treatment effectiveness in major depressive disorder OA Levada, AS Troyan Annals of general psychiatry 16 (1), 38, 2017 | 50 | 2017 |
Cognitive-functional relationships in major depressive disorder: Crucial data from a Ukrainian open-label study of vortioxetine versus escitalopram OA Levada, AS Troyan Journal of affective disorders 250, 114-122, 2019 | 43 | 2019 |
Белок S100В: нейробиология, значение при неврологической и психиатрической патологии АВ Траилин, ОА Левада Международный неврологический журнал, 166-175, 2009 | 40 | 2009 |
Plasma brain-derived neurotrophic factor as a biomarker for the main types of mild neurocognitive disorders and treatment efficacy: a preliminary study OA Levada, NV Cherednichenko, AV Trailin, AS Troyan Disease markers 2016, 2016 | 34 | 2016 |
Brain-derived neurotrophic factor (BDNF): neurobiology and marker value in neuropsychiatry OA Levada, NV Cherednichenko Likars' ka sprava, 15-25, 2015 | 28 | 2015 |
Post-stroke depression OA Levada, EI Slivko Zhurnal Nevrologii I Psikhiatrii Imeni SS Korsakova, 73-79, 2006 | 22 | 2006 |
The diagnostic value of the combination of serum brain-derived neurotrophic factor and insulin-like growth factor-1 for major depressive disorder diagnosis and treatment efficacy AS Troyan, OA Levada Frontiers in Psychiatry 11, 514735, 2020 | 18 | 2020 |
Serum insulin-like growth factor-1 as a potential marker for MDD diagnosis, its clinical characteristics, and treatment efficacy validation: data from an open-label … OA Levada, AS Troyan, IY Pinchuk BMC psychiatry 20, 1-10, 2020 | 15 | 2020 |
Major depressive disorder and accelerated aging from a peripheral IGF-1 overexpression perspective OA Levada, AS Troyan Medical Hypotheses 138, 109610, 2020 | 12 | 2020 |
P300 potential parameters at the stages of formation of the subcortical vascular dementia in elderly OA Levada, AV Trailin, AL Kvitka, OV Stolbinskaia Likars' ka Sprava, 60-66, 2014 | 11 | 2014 |
Serum level of S100B as a marker of progression of vascular mild cognitive impairment into subcortical vascular dementia and therapy effectiveness OA Levada, AV Trailin ЛІКАРСЬКА СПРАВА ВРАЧЕБНОЕ ДЕЛО, 59, 2012 | 10 | 2012 |
Актуальні питання геронтопсихіатрії ОАЛ ІЯ Пінчук, ВВ Чайковська, ЛА Стадник Тернопіль, 431, 2010 | 9* | 2010 |
Генетика и эпигенетика шизофрении // Нейро news. – 2012. – Т.6, No41. ЛОА Траилин А.В. Нейро news 6 (41), 18-28, 2012 | 8* | 2012 |
neuropsychiatric symptoms in Patients with the Main etiological Types of Mild neurocognitive Disorders: a hospital-Based case–control study OA Levada, NV Cherednichenko, AS Troyan Frontiers in Psychiatry 8, 251105, 2017 | 6 | 2017 |
Нейробиология депрессии: от анатомо-функциональных до молекулярных механизмов ОА Левада НевроNews 67 (3), 2015 | 6 | 2015 |
Etiology, clinical variants, diagnosis and treatment tactic of cerebellar infarction OA Levada Likars' ka Sprava, 3-6, 2003 | 6 | 2003 |
Судинна деменція: етіопатогенез, діагностика, сучасні стратегії лікування. Метод. рекомендації ІЯП ОА Левада МОЗ України, 25, 2009 | 5 | 2009 |
Serum serotonin level in patients with depression and panic attacks OA Levada, NV Cherednichenko, IR Rybak Likars' ka Sprava, 36-38, 2006 | 5 | 2006 |
Нейропсихологія болю ОА Левада НевроNews 35 (8), 2011 | 4 | 2011 |